186 CL2020, a human multilineage-differentiating stress enduring cells-rich product, has a potential to treat dystrophic epidermolysis bullosa
0301 basic medicine
0303 health sciences
03 medical and health sciences
DOI:
10.1016/j.jid.2017.07.183
Publication Date:
2017-09-08T15:02:26Z
AUTHORS (9)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....